1. Home
  2. NBHC vs RLAY Comparison

NBHC vs RLAY Comparison

Compare NBHC & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NBHC

National Bank Holdings Corporation

HOLD

Current Price

$38.72

Market Cap

1.6B

Sector

Finance

ML Signal

HOLD

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$10.36

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBHC
RLAY
Founded
2009
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.3B
IPO Year
2011
2020

Fundamental Metrics

Financial Performance
Metric
NBHC
RLAY
Price
$38.72
$10.36
Analyst Decision
Buy
Strong Buy
Analyst Count
3
6
Target Price
$45.33
$14.50
AVG Volume (30 Days)
499.1K
2.3M
Earning Date
04-28-2026
05-27-2026
Dividend Yield
3.29%
N/A
EPS Growth
N/A
31.78
EPS
2.85
N/A
Revenue
$47,100,000.00
$15,355,000.00
Revenue This Year
$39.32
N/A
Revenue Next Year
$6.74
$396.00
P/E Ratio
$13.65
N/A
Revenue Growth
2.86
53.44
52 Week Low
$32.83
$1.78
52 Week High
$42.99
$11.43

Technical Indicators

Market Signals
Indicator
NBHC
RLAY
Relative Strength Index (RSI) 36.76 60.91
Support Level $37.79 $9.06
Resistance Level $40.97 $11.43
Average True Range (ATR) 0.97 0.77
MACD -0.25 0.06
Stochastic Oscillator 11.50 56.56

Price Performance

Historical Comparison
NBHC
RLAY

About NBHC National Bank Holdings Corporation

National Bank Holdings Corp is a bank holding company. It provides various banking products and financial services to commercial, business, and consumer clients in the United States. The company offers deposit products including checking accounts, savings accounts, money market accounts, and other deposit accounts, including fixed-rate and fixed-maturity time deposits. It also provides commercial and industrial loans and leases. In addition, it offers treasury management solutions comprising online and mobile banking, commercial credit cards, wire transfers, automated clearing house, and electronic bill payments.

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

Share on Social Networks: